PROTECT AGAINST RSV WITH

Both people 60+ and those 18-59 at increased risk* can be protected against RSV with AREXVY

*Increased risk includes individuals 18 through 59 years of age with conditions like respiratory disease, cardiovascular disease, liver disease, kidney disease, diabetes, and for individuals 18 through 49 years of age, neurological or neuromuscular conditions.

AREXVY was proven effective in a large study with people 60+ years old.

OVER82%

EFFECTIVE

in preventing lung and lower airway infection from RSV in people aged 60 years and older

OVER94%

EFFECTIVE

in preventing lung and lower airway infection from RSV in people aged 60 years and older with asthma, diabetes, chronic obstructive pulmonary disease (COPD), chronic heart failure, advanced liver or kidney disease, or any chronic respiratory or pulmonary disease

Effectiveness in adults 18-59 at increased risk was based on the immune responses compared to that seen in adults 60+.

What Is RSV?

RSV is a contagious respiratory virus. It can lead to severe infections affecting the lungs and lower airways.

About RSV

What Is AREXVY?

AREXVY is an FDA-approved vaccine used to prevent lung and lower airway infection caused by RSV in people 60 years and older or those 18 through 59 years old at increased risk.

AREXVY is not for use in pregnant people.

About AREXVY

Is AREXVY for Me?

See sample questions to ask your doctor about RSV and getting vaccinated.

GET STARTED

Helpful tip: You can get AREXVY at the same time as your flu shot
Helpful tip: You can get AREXVY at the same time as your flu shot

GET AREXVY

See when and where you can get AREXVY.

FIND AREXVY

GET VACCINE REMINDERS

Sign up for reminders about getting AREXVY.

REMIND ME

STAY INFORMED

Sign up for more information about RSV and AREXVY.